Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.
Posted on Nov 25, 2015
EDEN PRAIRIE, Minn., Nov. 25, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Financial Officer, Claudia Drayton, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York, NY on December 2nd at 12:00 PM ET.
About the C-P...
Posted on Nov 3, 2015
EDEN PRAIRIE, Minn., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the third quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and pr...
Posted on Oct 27, 2015
EDEN PRAIRIE, Minn., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its third quarter results will be released on Tuesday, November 3, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, ...
Events & Presentations
Posted on Nov 7, 2015
Posted on Nov 3, 2015 at 9:00 AM ET
Posted on Oct 13, 2015